Estrella Immunopharma, Inc. (ESLA)
$0.33-19.51%Close
SELLCRISIS · day 29
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- 0.93
- P/E (TTM)
- -1.74
- Short % float
- 1.26%
- Days to cover
- 4.7
- SI change
- +39.2%
- 1W
- -25.00%
- 1M
- -50.00%
- vs SPY 1W
- -25.42%
- vs SPY 1M
- -52.06%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on ESLA?
- LOPJLB’s latest quantitative signal on Estrella Immunopharma, Inc. (ESLA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ESLA in?
- Estrella Immunopharma, Inc. (ESLA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Estrella Immunopharma, Inc. (ESLA) do?
- Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse l…